Paediatric Cataract Initiative seeks applicants for inaugural research grant

Article

The Paediatric Cataract Initiative is now accepting applicants for its inaugural single small research grant.

The Paediatric Cataract Initiative is now accepting applicants for its inaugural single small research grant. US$75,000 will be awarded to a qualified individual, institution or organization investigating the causes of paediatric cataract and/or improved treatment tools and protocols. The submission deadline is November 15, 2010.

The grant is intended to support innovative research that can be carried out in 12 months with limited resources. Applicants may submit more than one proposal provided that each is scientifically distinct. Please visit www.pediatriccataract.org/grant_funding.html to download the complete request for proposals.

The newly founded Paediatric Cataract Initiative is a partnership between the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation to identify, fund and promote innovative methods of overcoming paediatriccataract - a debilitating childhood condition that clouds the eye's natural lens - for the long-term benefit of children, their families and their communities.

Follow the Initiative on Twitter and Facebook.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.